{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:42:26Z","timestamp":1792075346464,"version":"4.4.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multisystem inflammatory syndrome in children (MIS-C) is a post-COVID-19 condition resembling Kawasaki disease, including developing coronary aneurysms. Optimal treatment remains uncertain. This study aims to identify effective therapies for preventing aneurysms in MIS-C and associated risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This multicenter, ambispective study included hospitalized patients 0\u201318 years old with MIS-C between March 2020 and June 2023 from cohorts in Poland, Spain, Catalonia and Colombia. Logistic regression analyzed aneurysm risk factors. Treatment efficacy was assessed using Kaplan\u2013Meier and Cox proportional hazards models, with post hoc Tukey\u2019s tests for pairwise comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 853 patients, 33 (4%) developed aneurysms, with a median age of 5.86 years (interquartile range, 3.00\u201311.7). All immunomodulatory treatments reduced aneurysm risk compared with no immunomodulatory treatment: corticosteroids + intravenous immunoglobulin (IVIG) [odds ratio (OR): 0.29; 95% confident interval (CI): 0.13\u20130.68], corticosteroids alone (OR: 0.27; 95% CI: 0.04\u20131.02) and IVIG alone (OR: 0.49; 95% CI: 0.18\u20131.28). Kaplan\u2013Meier analysis showed a significantly lower 7-day aneurysm-free probability without immunomodulatory treatment (92%; 95% CI: 87%\u201396%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.011). Hazard ratios indicated a reduction in aneurysm risk with corticosteroids+IVIG [hazard ratio (HR) = 0.29; 95% CI: 0.13\u20130.65], corticosteroids alone (HR = 0.25; 95% CI: 0.06\u20131.13) and IVIG alone (HR = 0.49; 95% CI: 0.19\u20131.25), but no significant differences were observed between these treatments. No additional aneurysm risk factors were identified.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Corticosteroids, IVIG and their combination appear to be protective against aneurysms in children with MIS-C compared with no immunomodulatory treatment. Although the 3 therapies showed no significant differences when compared with each other, only the combination significantly reduced the risk. Corticosteroids may still be a useful option when IVIG is limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000004922","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T21:04:56Z","timestamp":1755637496000},"page":"1173-1180","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Both Corticosteroids and Intravenous Immunoglobulin Protect From Aneurysms in Children With Multisystem Inflammatory Syndrome: A Multicenter Ambispective Study"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-903X","authenticated-orcid":false,"given":"Cinta","family":"Moraleda","sequence":"first","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Pediatrics Deparment, Hospital Universitario 12 de Octubre"},{"name":"Deparment of Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Ludwikowska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Wroclaw Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irati","family":"Gastesi","sequence":"additional","affiliation":[{"name":"Deparment of Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Okarska-Napiera\u0142a","sequence":"additional","affiliation":[{"name":"Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Epalza","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Pediatrics Deparment, Hospital Universitario 12 de Octubre"},{"name":"Deparment of Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Paredes-Carmona","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitari Arnau de Vilanova, Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ram\u00edrez Varela","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Universidad de los Andes, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kulboka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miron","family":"Kursa","sequence":"additional","affiliation":[{"name":"Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw"},{"name":"University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Fumad\u00f3","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Sant Joan de D\u00e9u, Esplugues de Llobregat"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Mart\u00ednez-Mej\u00edas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Consorci Sanitari de Terrassa, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dom\u00ednguez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Deparment of Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"},{"name":"Deparment of Biomedicine, Universidad Europea de Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luc\u00eda","family":"Mesa-Rubio","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Universidad de los Andes, Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Kuchar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Grasa","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department, Hospital Universitario La Paz"},{"name":"La Paz Institute for Health Research (IdiPAZ)"},{"name":"Biomedical Research Network Center for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Soriano-Arandes","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunodeficiencies Unit, Children\u2019s Hospital, Vall d\u2019Hebron Barcelona Hospital Campus, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szenborn","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Wroclaw Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Iglesias-Bouzas","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Hospital Ni\u00f1o Jes\u00fas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Roche-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, Pediatrics Deparment, Hospital Universitario 12 de Octubre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Tagarro","sequence":"additional","affiliation":[{"name":"Deparment of Instituto de Investigaci\u00f3n 12 de Octubre (imas12), Fundaci\u00f3n de Investigaci\u00f3n Biom\u00e9dica Hospital 12 de Octubre, Madrid, Spain"},{"name":"Department of Pediatrics, Infanta Sof\u00eda University Hospital, Fundaci\u00f3n para la Investigaci\u00f3n Biom\u00e9dica e Innovaci\u00f3n Hospital Universitario Infanta Sof\u00eda y Hospital del Henares (FIIB HUIS HHEN)"},{"name":"Deparment of Medicine, Faculty of Medicine, Universidad Europea de Madrid, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the International Working Group on Aneurysms in MIS-C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1093\/cid\/ciaa1042","article-title":"Multi-inflammatory syndrome in children related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Spain.","volume":"72","author":"Moraleda","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R2-20260615","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1172\/JCI141718","article-title":"Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?","volume":"130","author":"Yeung","year":"2020","journal-title":"J Clin Invest"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2019.01.092","article-title":"Hemodynamic variables in aneurysms are associated with thrombotic risk in children with Kawasaki disease.","volume":"281","author":"Grande Gutierrez","year":"2019","journal-title":"Int J Cardiol"},{"key":"R4-20260615","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/art.42062","article-title":"American college of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3.","volume":"74","author":"Henderson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jama.2021.0694","article-title":"Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children.","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa2102605","article-title":"Multisystem inflammatory syndrome in children \u2014 initial therapy and outcomes.","volume":"385","author":"Son","year":"2021","journal-title":"N Engl J Med"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12969-022-00726-2","article-title":"A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.","volume":"20","author":"Son","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S2352-4642(23)00316-4","article-title":"Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.","volume":"8","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2102968","article-title":"Treatment of multisystem inflammatory syndrome in children.","volume":"385","author":"McArdle","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00431-022-04649-8","article-title":"Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.","volume":"182","author":"Tagarro","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R12-20260615","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2352-4642(23)00020-2","article-title":"Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.","volume":"7","author":"Welzel","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/jama.2021.0694","article-title":"Intravenous immunoglobulin plus methylprednisolone versus immunoglobulin alone in multisystem inflammatory syndrome in children with COVID-19: a multicenter, randomized trial.","volume":"325","author":"Ouldali","year":"2021","journal-title":"JAMA"},{"key":"R14-20260615","first-page":"534","article-title":"Short-term outcomes of corticosteroid monotherapy in multisystem inflammatory syndrome in children.","volume":"176","author":"Villacis-Nunez","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00431-021-04306-6","article-title":"Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children.","volume":"181","author":"Tagarro","year":"2022","journal-title":"Eur J Pediatr"},{"key":"R18-20260615","doi-asserted-by":"crossref","first-page":"23562","DOI":"10.1038\/s41598-021-02669-2","article-title":"Distinct characteristics of multisystem inflammatory syndrome in children in Poland.","volume":"11","author":"Ludwikowska","year":"2021","journal-title":"Sci Rep"},{"key":"R19-20260615","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"R20-20260615","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/S2665-9913(23)00029-2","article-title":"Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study.","volume":"5","author":"Channon-Wells","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R21-20260615","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2020.10.026","article-title":"Multisystem inflammatory syndrome in children: survey of protocols for early hospital evaluation and management.","volume":"229","author":"Dove","year":"2021","journal-title":"J Pediatr"},{"key":"R22-20260615","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/CIRCULATIONAHA.120.050147","article-title":"Addition of corticosteroids to immunoglobulins is associated with recovery of cardiac function in multi-inflammatory syndrome in children.","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"R23-20260615","doi-asserted-by":"crossref","first-page":"102358","DOI":"10.1016\/j.eclinm.2023.102358","article-title":"Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the.","volume":"67","author":"Andre","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R24-20260615","first-page":"659","article-title":"High-dose intravenous gamma globulin for Kawasaki disease [in Japanese].","volume":"17","author":"Furusho","year":"1983","journal-title":"Kiso To Rinsho"},{"key":"R25-20260615","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease.","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"R26-20260615","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin.","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"R27-20260615","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"R28-20260615","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1542\/peds.96.6.1057","article-title":"The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.","volume":"96","author":"Durongpisitkul","year":"1995","journal-title":"Pediatrics"},{"key":"R29-20260615","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","article-title":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.","volume":"131","author":"Terai","year":"1997","journal-title":"J Pediatr"},{"key":"R30-20260615","first-page":"CD014884","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease.","volume":"1","author":"Broderick","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20260615","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1542\/peds.63.2.175","article-title":"Kawasaki disease: Effect of treatment on coronary artery involvement.","volume":"63","author":"Kato","year":"1979","journal-title":"Pediatrics"},{"key":"R32-20260615","first-page":"CD011188","article-title":"Corticosteroids for the treatment of Kawasaki disease in children.","volume":"1","author":"Wardle","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R33-20260615","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"R34-20260615","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/rheumatology\/keaa512","article-title":"High risk of coronary artery aneurysm in Kawasaki disease.","volume":"60","author":"Mossberg","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R35-20260615","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R36-20260615","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00431-023-04862-z","article-title":"Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain.","volume":"182","author":"Pino","year":"2023","journal-title":"Eur J Pediatr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:00:32Z","timestamp":1781546432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004922","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}